Varma Mutual Pension Insurance Co has increased its stake in Regeneron Pharmaceuticals by 9.3%, now owning 19,888 shares valued at approximately $11.18 million. This increase comes as Regeneron reported strong quarterly earnings, beating analyst expectations with an EPS of $11.44 and revenue of $3.88 billion, and also announced an increased quarterly dividend of $0.94. The stock currently holds a “Moderate Buy” consensus rating with an average price target of $793.81.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Varma Mutual Pension Insurance Co Increases Stake in Regeneron Pharmaceuticals, Inc. $REGN
Varma Mutual Pension Insurance Co has increased its stake in Regeneron Pharmaceuticals by 9.3%, now owning 19,888 shares valued at approximately $11.18 million. This increase comes as Regeneron reported strong quarterly earnings, beating analyst expectations with an EPS of $11.44 and revenue of $3.88 billion, and also announced an increased quarterly dividend of $0.94. The stock currently holds a “Moderate Buy” consensus rating with an average price target of $793.81.